EVE Health Group Company Description

EVE Health Group Limited, a life sciences and healthcare company, engages in the development and commercialization of pharmaceutical products in Australia.

It operates in two segments, Meluka (Branded Wellness Consumer Products) and Nextract (Pharmaceutical Products and Intellectual Property).

Its lead product is the Dyspro, a formulation developed to address dysmenorrhoea and Endometriosis Pain; and Libbo, an oral dissolving film for erectile dysfunction.

The company also develops Apixaban to treat anticoagulation. The company was formerly known as EVE Investments Limited.

EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

EVE Health Group Limited

Country	Australia
Founded	2003
Industry	Packaged Foods
Sector	Consumer Staples
CEO	Benedict Rohr

Contact Details

Address: 245 Churchill Avenue Subiaco, Washington 6008 Australia
Phone	61 8 6465 5500
Website	evehealthgroup.com.au

Stock Details

Ticker Symbol	EVE
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000EVE3
SIC Code	2090

Key Executives

Name	Position
Benedict James Rohr	Chief Operating Officer
Dr. Stuart Gunzburg	CSO and Executive Director
Steven Luke Jackson BEc, C.P.A.	Chief Financial Officer and Company Secretary
Rebecca Bak	Marketing Manager